Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
【発明の名称】新生物形成の治療における組合わせ療法としてインテグリン拮抗剤及び放射線治療を使用する方法
Document Type and Number:
Japanese Patent JP2002533404
Kind Code:
A
Abstract:
The present invention provides methods to treat neoplasia disorders in a mammal using a combination of radiation and an integrin antagonist.

More Like This:
WO/2013/147645METHOD FOR PRODUCING DRUGS AND BIOLOGICALLY ACTIVE AGENTS
JP2000503764INDUSTRIAL APPLICABILITY The use of RC-9 in the diagnosis and treatment of proliferative arterial disease.
WO/2004/108121USE OF HIF ALPHA STABILIZERS FOR ENHANCING ERYTHROPOIESIS
Inventors:
McPann, John Pea
Gordon, Gary
Cunningham, James Jay
Gateley, stephen tee
Corkey, Alan Tea
Masefeller, jamel
Application Number:
JP2000590666A
Publication Date:
October 08, 2002
Filing Date:
December 22, 1999
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
G.D.Searl and Company
International Classes:
A61K31/00; A61K31/07; A61K31/122; A61K31/135; A61K31/136; A61K31/138; A61K31/16; A61K31/165; A61K31/166; A61K31/18; A61K31/191; A61K31/192; A61K31/197; A61K31/198; A61K31/203; A61K31/255; A61K31/28; A61K31/282; A61K31/337; A61K31/341; A61K31/351; A61K33/243; A61K31/353; A61K45/00; A61K31/36; A61K31/381; A61K31/402; A61K31/415; A61K31/4162; A61K31/4164; A61K31/4168; A61K31/4178; A61K31/4184; A61K31/4188; A61K31/4196; A61K31/42; A61K31/421; A61K31/422; A61K31/425; A61K31/427; A61K31/429; A61K31/435; A61K31/4353; A61K31/437; A61K31/4375; A61K31/44; A61K31/4402; A61K31/4418; A61K31/4427; A61K31/4433; A61K31/4439; A61K31/444; A61K31/445; A61K31/4453; A61K31/45; A61K31/451; A61K31/4535; A61K31/4545; A61K31/4709; A61K31/4741; A61K31/4745; A61K31/475; A61K31/496; A61K31/501; A61K31/505; A61K31/506; A61K31/51; A61K31/519; A61K31/525; A61K31/541; A61K31/55; A61K31/5513; A61K31/566; A61K31/567; A61K31/569; A61K31/57; A61K31/575; A61K31/66; A61K31/664; A61K31/675; A61K31/704; A61K31/7048; A61K31/7068; A61K33/04; A61K33/10; A61K38/00; A61K39/395; A61K41/00; A61K45/06; A61P1/00; A61P11/00; A61P13/10; A61P15/00; A61P15/14; A61P17/00; A61P35/00; A61P41/00; A61P43/00; C07D211/54; C07D211/66; C07D211/96; C07D213/74; C07D261/18; C07D309/08; C07D401/06; C07D401/12; C07D403/12; C07D405/12; C07D413/12; C07D417/12; C07D471/04; C07K5/023; C07K5/062; C07K16/18; (IPC1-7): A61K45/00; A61K31/422; A61K31/4375; A61K31/44; A61K31/4439; A61K31/5513; A61K39/395; A61P1/00; A61P11/00; A61P13/10; A61P15/14; A61P35/00; A61P43/00; C07K5/023; C07K16/18
Attorney, Agent or Firm:
Tadahiko Ito



 
Previous Patent: JP2002533403

Next Patent: 新生物の治療における組み合わせ療法としてのマトリックスメタロプロテ...